In the context of BC, ID4 is highly expressed in triple-negative breast cancer (TNBC), 70% of which belong to the basal-like breast cancer (BLBC) molecular subtype [17, 18]. The gene discussed is ID4; the disease is triple-negative breast carcinoma.